there is a justified suspicion that the unit packs of the medicinal product contain a product with a significantly higher dose of active substance than indicated on the outer labelling, creating a real risk that patients will take several times the intended dose. Potential effects: overdose of inhaled medicine, increased corticosteroid side effects, complications in sensitive patients.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Benodil from batch 054223, check the batch number on the packaging and return the medicine to the pharmacy; if the medicine has been taken, consult a doctor.
Marketing of batch 054223 of Benodil 0.25 mg/ml, suspension for nebulisation, was suspended throughout the country and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related